Blueprint Medicines Corporation (Nasdaq: BPMC) today reported financial results, provided a business update for the first ...

Before she was 35, Suki Tipp and her family lived what she would describe as a busy, but relatively normal life. But then ...

Health experts have warned against underestimating the risks of "indolent tumors" as China observes its 30th "National ...

Cliff Benfield Indolent Allen follows Allen, a lazy college student who brings out the worst in every social circle he nudges into. Advertisement ...

Jill Zinsmeyer came to Austin for love, but Austin didn't love her. Living in Napa Valley, Calif., before the move, Zinsmeyer ...

Harvard’s endowment is currently $50.7 billion. That means that the first year, the state would extract about $1.25 billion ...

Among more than 1,300 patients diagnosed with HCC, the median survival reached 37 months for those with screening-detected ...

Blueprint boosts Ayvakit peak sales estimate to $2B as key rare disease expansion accelerates Meanwhile, Blueprint these days ...

Purpose. The pharmacology, efficacy, safety, and dosage and administration of bendamustine and its use in indolent non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL) are reviewed.

HAMPTON ROADS, Va. — Hematologist and Oncologist Dr. Pankit Vachhani and Suki Tipp, a woman living with Indolent Systemic Mastocytosis, join Coast Live to discuss the debilitating disease ...

My name is Towanda, and I will be your operator today. As a reminder, this call is being recorded for replay purposes. I ...

The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin’s lymphoma. Its product candidates also include ...